<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>2024 (12) TMI 1762 - ITAT COCHIN</title>
    <link>https://www.taxtmi.com/caselaws?id=468541</link>
    <description>Transfer pricing adjustments for corporate guarantee commission, notional interest on delayed trade receivables, and alleged shortfall in interest on a subsidiary loan were not finally upheld; the Tribunal remitted them for reconsideration, noting comparables, business practice on receivables, and foreign-currency borrowing terms. The proposed mark-to-market addition on forward contracts was also set aside for de novo verification because the tax computation treatment under Ind AS and ICDS had not been properly examined. An alternate deduction claim for expenditure earlier denied under weighted deduction for in-house research and development was permitted to be raised and remitted for fresh adjudication. The section 14A disallowance was likewise sent back for factual verification on own funds, investment base, exclusion of foreign subsidiaries, and possible duplication.</description>
    <language>en-us</language>
    <pubDate>Wed, 11 Dec 2024 00:00:00 +0530</pubDate>
    <lastBuildDate>Tue, 12 May 2026 16:15:12 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=901551" rel="self" type="application/rss+xml"/>
    <item>
      <title>2024 (12) TMI 1762 - ITAT COCHIN</title>
      <link>https://www.taxtmi.com/caselaws?id=468541</link>
      <description>Transfer pricing adjustments for corporate guarantee commission, notional interest on delayed trade receivables, and alleged shortfall in interest on a subsidiary loan were not finally upheld; the Tribunal remitted them for reconsideration, noting comparables, business practice on receivables, and foreign-currency borrowing terms. The proposed mark-to-market addition on forward contracts was also set aside for de novo verification because the tax computation treatment under Ind AS and ICDS had not been properly examined. An alternate deduction claim for expenditure earlier denied under weighted deduction for in-house research and development was permitted to be raised and remitted for fresh adjudication. The section 14A disallowance was likewise sent back for factual verification on own funds, investment base, exclusion of foreign subsidiaries, and possible duplication.</description>
      <category>Case-Laws</category>
      <law>Income Tax</law>
      <pubDate>Wed, 11 Dec 2024 00:00:00 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/caselaws?id=468541</guid>
    </item>
  </channel>
</rss>